STOCK TITAN

Lifemd Inc - LFMD STOCK NEWS

Welcome to our dedicated page for Lifemd news (Ticker: LFMD), a resource for investors and traders seeking the latest updates and insights on Lifemd stock.

LifeMD, Inc. (LFMD) operates a leading telehealth platform connecting patients with HIPAA-compliant care solutions. This page serves as the definitive source for verified company news, providing investors and healthcare professionals with timely updates on key developments.

Access consolidated information on earnings reports, strategic partnerships, regulatory milestones, and service expansions. Our curated news collection simplifies tracking LFMD's progress in digital prescription services, remote diagnostics, and integrated telehealth solutions.

Discover updates across three core areas: financial performance announcements, operational developments in WorkSimpli software solutions, and advancements in secure patient-provider communication technologies. All content is sourced from official releases and trusted financial publications.

Bookmark this page for efficient monitoring of LifeMD's innovations in cloud-based pharmacy services, nutritional supplement offerings, and telehealth infrastructure. Return regularly to stay informed about this evolving leader in virtual healthcare delivery.

Rhea-AI Summary
LifeMD, Inc.TM (Nasdaq: LFMD) announced a strategic alliance with Medifast (NYSE: MED) to integrate LifeMD’s telehealth platform and GLP-1 offering for medically qualified patients with OPTAVIA Coach-guided, healthy lifestyle solution. Medifast has invested $20 million, including a $10 million payment in support of the collaboration and a $10 million purchase of LifeMD common stock.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.42%
Tags
partnership
-
Rhea-AI Summary
Medifast (MED) expands into the medically supported weight loss market through a collaboration with LifeMD (LFMD), making a $20 million capital commitment to drive growth. The company will discontinue its quarterly cash dividend to invest in customer acquisition and experience, aiming to reignite growth in the health and wellness landscape. The collaboration is expected to address the escalating obesity crisis and tap into the $100 billion weight loss market by 2030.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.42%
Tags
none
-
Rhea-AI Summary
LifeMD, Inc. (LFMD) to Participate in RWJBarnabas Health Telehealth Symposium, Showcasing the Role of Telehealth in Quality Patient Care
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.89%
Tags
conferences
Rhea-AI Summary
LifeMD, Inc. (LFMD) to participate in upcoming investor conferences and panel discussions. CEO Justin Schreiber to discuss GLP-1s at Cantor Fitzgerald panel and digital health at BTIG forum. Sidoti's Small-Cap Virtual Conference to feature corporate overview and one-on-one investor meetings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.03%
Tags
conferences
-
Rhea-AI Summary
LifeMD, Inc. (Nasdaq: LFMD) reported a 23% year-over-year revenue increase to $38.6 million, with record revenues for telehealth and WorkSimpli. Adjusted EPS was $0.08 per share, compared to a loss of $0.03 in the previous year. Weight Management revenue more than quadrupled, and telehealth subscribers grew 22% to a record 207,000 patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.89%
Tags
-
Rhea-AI Summary
LifeMD (NASDAQ: LFMD) achieved 855% revenue growth, ranking 166 on the Deloitte Technology Fast 500™. The growth is attributed to the differentiated, end-to-end care platform and affiliated medical group, supporting offerings like the LifeMD Weight Management Program.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
none
Rhea-AI Summary
LifeMD, Inc. will report financial results for Q3 2023 on November 8th and host a conference call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.22%
Tags
conferences earnings
-
Rhea-AI Summary
Joint research study by Particle Health and LifeMD demonstrates that Particle's platform can help healthcare providers contextualize patient data and identify eligibility for GLP-1 treatment, potentially saving physicians time and improving patient outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.79%
Tags
none
-
Rhea-AI Summary
LifeMD, Inc. (Nasdaq: LFMD) to participate in investor conferences in October.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
conferences
Rhea-AI Summary
LifeMD, Inc. authorizes cash dividend of $0.5546875 per share for its 8.875% Series A Cumulative Perpetual Preferred Stock, payable on October 16, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.42%
Tags
dividends
Lifemd Inc

Nasdaq:LFMD

LFMD Rankings

LFMD Stock Data

242.31M
36.24M
16.28%
36.85%
15.18%
Health Information Services
Services-offices & Clinics of Doctors of Medicine
Link
United States
NEW YORK